Intra-Cellular Therapies ... (ITCI)
NASDAQ: ITCI
· Real-Time Price · USD
131.87
0.00 (0.00%)
At close: Apr 01, 2025, 3:59 PM
Intra-Cellular Therapies Revenue
Intra-Cellular Therapies reported an annual revenue of $680.85M, reflecting a 46.62% growth. For the quarter ending December 31, 2024, Intra-Cellular Therapies generated $199.22M in revenue.
Revenue (ttm)
680.85M
Revenue Growth
46.62%
Price / Sales Ratio
12.65
Revenue / Employee
791.69K
Employees
860
Market Cap
14.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 680.85M | +46.62% |
| Dec 31, 2023 | 464.37M | +86.40% |
| Dec 31, 2022 | 249.13M | +204.91% |
| Dec 31, 2021 | 81.71M | +262.65% |
| Dec 31, 2020 | 22.53M | +37071.49% |
| Dec 31, 2019 | 60.61K | +Infinity% |
| Dec 31, 2018 | 0 | -100.00% |
| Dec 31, 2017 | 245.84K | -25.66% |
| Dec 31, 2016 | 330.7K | +261.96% |
| Dec 31, 2015 | 91.36K | -84.17% |
| Dec 31, 2014 | 577.3K | -78.91% |
| Dec 31, 2013 | 2.74M | -12.22% |
| Mar 31, 2013 | 3.12M | n/a |